ArticleEFSA journal. European Food Safety Authority2017
Bluetongue: control, surveillance and safe movement of animals.
Article in EFSA journal. European Food Safety Authority, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 55 citations in OpenAlex.
- Nationwide Distribution and Prevalence of Epizootic Haemorrhagic Disease Virus Infection in Portugal (2023-2025).Viruses · 2026Article
- The changing landscape of bluetongue in northern Europe.Journal of medical entomology · 2026Review
- Knowledge mapping of risk mitigation measures against vector-borne diseases.EFSA journal. European Food Safety Authority · 2026Article
- Bluetongue Virus in Cervids in Piedmont During the 2024-2025 Outbreak.Veterinary medicine and science · 2026Article
- Exceptional Bluetongue Epidemic Caused by Co-Circulation of Several Serotypes in Spain in 2024.Microorganisms · 2026Article
- High Seroprevalence of Bluetongue Virus Serotype 3 in Belgian Cattle and Sheep After the 2024 Epidemic.Viruses · 2026Article
- Farmers' views and attitudes towards bovine tuberculosis and bluetongue in Northern Ireland using semi-structured interviews.Irish veterinary journal · 2026Article
- Preparation for a potential outbreak of bluetongue virus in Ireland: surveillance design to estimate local prevalence after an initial case detection.Irish veterinary journal · 2025Article
- Silent circulation of Bluetongue and Schmallenberg viruses in Culicoides biting midges in northwestern Italy: implications for the 2024 BTV outbreak.Journal of medical entomology · 2025Article
- Bluetongue in ruminants: Global epidemiology, pathogenesis, and advances in diagnostic and control strategies within a One Health framework.Veterinary world · 2025Review
- Bluetongue's New Frontier-Are Dogs at Risk?Veterinary sciences · 2025Review
- Impact of BTV-3 Circulation in Belgium in 2024 and Current Knowledge Gaps Hindering an Evidence-Based Control Program.Viruses · 2025Article
- First Expert Elicitation of Knowledge Conducted in 2023 on Possible Drivers of Observed Increasing Epizootic Haemorrhagic Disease Incidence in Europe.Veterinary medicine international · 2025Article
- Review
- Bluetongue Virus Infection in Farm Dogs Exposed to an Infected Sheep Flock in South Africa.Transboundary and emerging diseases · 2024Article
- Serological and molecular prevalence study of bluetongue virus in small domestic ruminants in Morocco.Scientific reports · 2022Article
- Bluetongue Virus Infections in Cattle Herds of Manabí Province of Ecuador.Pathogens (Basel, Switzerland) · 2021Article
- The threat of veterinary medicinal products and biocides on pollinators: A One Health perspective.One health (Amsterdam, Netherlands) · 2021Review
- Scientific Opinion on the assessment of the control measures of the category A diseases of Animal Health Law:EFSA journal. European Food Safety Authority · 2021Article
- An updated review on bluetongue virus: epidemiology, pathobiology, and advances in diagnosis and control with special reference to India.The veterinary quarterly · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The performance of different bluetongue control measures related to both vaccination and protection from bluetongue virus (BTV) vectors was assessed. By means of a mathematical model, it was concluded that when vaccination is applied on 95% of animals even for 3 years, bluetongue cannot be eradicated and is able to re-emerge. Only after 5 years of vaccination, the infection may be close to the eradication levels. In the absence of vaccination, the disease can persist for several years, reaching an endemic condition with low level of prevalence of infection. Among the mechanisms for bluetongue persistence, the persistence in the wildlife, the transplacental transmission in the host, the duration of viraemia and the possible vertical transmission in vectors were assessed. The criteria of the current surveillance scheme in place in the EU for demonstration of the virus absence need revision, because it was highlighted that under the current surveillance policy bluetongue circulation might occur undetected. For the safe movement of animals, newborn ruminants from vaccinated mothers with neutralising antibodies can be considered protected against infection, although a protective titre threshold cannot be identified. The presence of colostral antibodies interferes with the vaccine immunisation in the newborn for more than 3 months after birth, whereas the minimum time after vaccination of animal to be considered immune can be up to 48 days. The knowledge about vectors ecology, mechanisms of over-wintering and criteria for the seasonally vector-free period was updated. Some
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.